Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin´s Lymphomas”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Not applicableStudy completedNCT01870479
What this trial is testing

Music & Cancer - Live Music During Chemotherapy

Who this might be right for
Non Hodgkin´s LymphomasHodgkin´s Lymphomas
Margrethe Langer Bro 143
Testing effectiveness (Phase 2)Study completedNCT00346684
What this trial is testing

Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)

Who this might be right for
Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)
University of Cologne
Early research (Phase 1)Active Not RecruitingNCT02879695
What this trial is testing

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Ended earlyNCT06561425
What this trial is testing

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Lakefront Biotherapeutics NV 130
Early research (Phase 1)Study completedNCT02920697
What this trial is testing

Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)B-Cell Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)
Institut de Recherches Internationales Servier 65
Large-scale testing (Phase 3)Study completedNCT00264953
What this trial is testing

HD11 for Intermediate Stages

Who this might be right for
Hodgkin´s Lymphoma
University of Cologne 1,395
Testing effectiveness (Phase 2)UnknownNCT01653067
What this trial is testing

STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Mathias Witzens-Harig 88
Large-scale testing (Phase 3)UnknownNCT02772822
What this trial is testing

A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Sinocelltech Ltd. 330
Not applicableUnknownNCT01151358
What this trial is testing

Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy

Who this might be right for
Follicular Lymphoma
University Hospital, Saarland 150
Not applicableStudy completedNCT07653386
What this trial is testing

Clinical Trial of an Ointment in Patients With Mild and Moderate Atopic Dermatitis

Who this might be right for
Mild and Moderate Atopic Dermatitis PatientsAtopic Dermatitis (AD)
VinUniversity 90
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT06137144
What this trial is testing

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Who this might be right for
LymphomaNon-Hodgkin LymphomaHodgkin Lymphoma+4 more
AstraZeneca 161
Large-scale testing (Phase 3)Ended earlyNCT00133302
What this trial is testing

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Who this might be right for
Non-Hodgkin's Lymphoma
Japan Clinical Oncology Group 450
Testing effectiveness (Phase 2)Looking for participantsNCT06066203
What this trial is testing

GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies

Who this might be right for
Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT00946374
What this trial is testing

Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma

Who this might be right for
Mantle-Cell Lymphoma
Heidelberg University 20
Very early researchActive Not RecruitingNCT03684980
What this trial is testing

LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma

Who this might be right for
Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Looking for participantsNCT06697184
What this trial is testing

Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Who this might be right for
Chronic Lymphocytic LeukemiaCLLMantle Cell Lymphoma+1 more
BeOne Medicines 258
Post-approval studies (Phase 4)UnknownNCT05490953
What this trial is testing

Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Guadalajara 30
Large-scale testing (Phase 3)UnknownNCT00884364
What this trial is testing

Exercise During Chemotherapy for Patients With Hematological Malignancies

Who this might be right for
Hematological DiseasesHematological Malignancies
Charite University, Berlin, Germany 60
Not applicableLooking for participantsNCT07059741
What this trial is testing

Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University 20
Next Page